Rurioctocog alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRurioctocog alfa
Drug Alias NameRecombinant anti-haemophilic factor辛凝血素α凝血素-8αRurioctocog αoctocogum alfa +[14] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/07/25
Country/TerritoryCzechiaBelgiumBulgaria +[21] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBaxalta Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Manufacturing Austria AgShire PharmaceuticalsBaxalta Incorporated
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksDrugBankKEGG